ReviewCurrent hypertension reports2010
Masked hypertension: evidence of the need to treat.
Review in Current hypertension reports, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.
- Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data and meta-analyses.Current hypertension reports · 2013Pooled it
- Masked hypertension in diabetes mellitus: treatment implications for clinical practice.Hypertension (Dallas, Tex. : 1979) · 2013Pooled it
- Masked hypertension in obesity: potential predictors and arterial damage.Blood pressure monitoring · 2017Trial
- Features from the photoplethysmogram and the electrocardiogram for estimating changes in blood pressure.Scientific reports · 2023Article
- Classification of Blood Pressure Levels Based on Photoplethysmogram and Electrocardiogram Signals with a Concatenated Convolutional Neural Network.Diagnostics (Basel, Switzerland) · 2022Article
- Self-Monitoring Home Blood Pressure in Community-Dwelling Older People: Age Differences in White-Coat and Masked Phenomena and Related Factors-The SONIC Study.International journal of hypertension · 2022Article
- Pulse arrival time as a surrogate of blood pressure.Scientific reports · 2021Article
- Prevalence of arterial hypertension, hemodynamic phenotypes, and left ventricular hypertrophy in children after coarctation repair: a multicenter cross-sectional study.Pediatric nephrology (Berlin, Germany) · 2020Article
- Epidemiological Impact and Clinical Consequences of Masked Hypertension: A Narrative Review.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2020Review
- The impact of apelin and relaxin plasma levels in masked hypertension and white coat hypertension.Journal of clinical hypertension (Greenwich, Conn.) · 2019Article
- Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population.JAMA cardiology · 2018Article
- Masked hypertension and kidney function decline: the Jackson Heart Study.Journal of hypertension · 2018Article
- Masked Hypertension: How to Identify and When to Treat?High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2016Review
- I Brazilian position paper on prehypertension, white coat hypertension and masked hypertension: diagnosis and management.Arquivos brasileiros de cardiologia · 2014Article
- Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring.Journal of human hypertension · 2013Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
The diagnosis of masked hypertension has been made easier with the widespread availability of home blood pressure monitoring devices with levels of accuracy comparable to ambulatory blood pressure monitoring. The negative impact of masked hypertension on cardiovascular morbidity and mortality is evidenced by numerous well-designed clinic-based and population-based studies. The relationship of masked hypertension and target organ damage is also well documented. These two factors, combined with the robust evidence of reduced cardiovascular morbidity and mortality achieved with blood pressure treatment, makes the argument for actively identifying patients with masked hypertension and prescribing treatment similar to that for patients with sustained hypertension. In this paper, we review the evidence for the cardiovascular prognosis of masked hypertension compared with sustained hypertension, we review its impact on target organ damage, we propose an algorithm for the treatment of patients with masked hypertension, and we point out the pitfalls in adopting such an approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.